Recent Publications

Below, you’ll find up-to-date articles about Glivec^® (imatinib).

Recent Publications

Hassan I, et al.
Surgically Managed Gastrointestinal Stromal tumours: A Comparative and Prognostic Analysis.
Annals of Surgical Oncollogy (2008 Jan)

Corless CL, Heinrich MC.
Molecular Pathobiology of Gastrointestinal Stromal Sarcomas.
Annual Review Pathology (2007 Oct 16) [Epub ahead of print]

Picard et al.
Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukaemia.
Blood (2007 September)

Kantarjian HM et al.
Diagnosis and management of chronic myeloid leukaemia: a survey of American and European practice patterns.
Cancer (2007 April)

Blay JY et al.
Prospective Multicentric Randomized Phase III Study of Imatinib in Patients With Advanced Gastrointestinal Stromal tumours Comparing Interruption Versus Continuation of Treatment Beyond 1 Year:
The French Sarcoma Group-JCO (2007- March)

deLabarthe A et al.
Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukaemia: results of the GRAAPH-2003 study.
Blood (2007 Feb)

Rousselot P et al.
Imatinib mesylate discontinuation in patients with chronic myelogenous leukaemia in complete molecular remission for more than 2 years.
Blood (2007 Jan)

Brian J. Druker, M.D. et al.
Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukaemia
The New England Journal of Medicine (2006 December)

Roy L et al.
Survival advantage from Imatinib compared to the combination Interferon-{alpha} plus Cytarabine in chronic phase CML: historical comparison between two phase 3 trials.
Blood (2006 April)

Common Patient Questions

Your patients may have questions about Glivec and its role in GIST and CML treatment. Find out the questions patients most frequently ask.

Get the Facts

Read the Glivec (imatinib) Fact Sheet (PDF) for concise information on Glivec, CML, and GIST.

You need Adobe® Reader®, available free from Adobe, to download, view, and print PDF files.

Disclaimer: This is an international website for Glivec^® (imatinib) and is intended for healthcare professionals outside the US. If you are a US resident, please click on the US Residents link at the top of this page. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.

THE GLIVEC INTERNATIONAL SITE

Recent Publications

Common Patient Questions

Get the Facts